ACADIA Pharmaceuticals Inc. Common Stock (NASDAQ: ACAD) last traded at $29.50, up 1.58% on the session. The quote above updates while this page is open; the figures below are drawn from ACADIA Pharmaceuticals Inc. Common Stock’s own filings and are restated only when a new one is published.
ACADIA Pharmaceuticals Inc. Common Stock trades on NASDAQ under the ticker ACAD. Its market capitalisation is $5.08 billion.
Valuation measures for ACADIA Pharmaceuticals Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.08B |
|---|---|
| Enterprise value | $5.13B |
| P/E ratio | 13.23 |
| Price / sales | 4.46 |
| Price / book | 3.89 |
| Beta | 0.87 |
Trailing-twelve-month figures tagged in ACADIA Pharmaceuticals Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.14B |
|---|---|
| Net income (TTM) | $380.48M |
| EPS (TTM) | $2.23 |
| Operating margin | 7.59% |
| Return on equity | 29.12% |
| Cash | $384.99M |
Range and volume for ACAD over the past 52 weeks.
| 52-week high | $30.96 |
|---|---|
| 52-week low | $19.69 |
| Volume | 1.07M |
| Average volume | 1.61M |
| Previous close | $29.04 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.